Literature DB >> 15380398

Early prediction of changes in weight during six weeks of treatment with antidepressants.

Hubertus Himmerich1, Andreas Schuld, Monika Haack, Christian Kaufmann, Thomas Pollmächer.   

Abstract

Weight gain is a frequent and important side effect of psychotropic treatment. We sought to determine weight change predictors during treatment with antidepressant drugs. In 24 patients weight, plasma levels of leptin, tumor necrosis factor-alpha (TNF-alpha and soluble TNF receptors were determined longitudinally and a multiple linear regression analysis was used to predict weight change from baseline to the sixth week of treatment. Changes of weight during the first week of treatment, but no other parameter, strongly predicted weight change until endpoint (adjusted R2 = 0.68, F = 50.45, df = 1,23, p < 0.001). Very early changes in weight during treatment with psychotropic drugs might be a simple and clinically useful predictor of future weight development.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15380398     DOI: 10.1016/j.jpsychires.2004.02.002

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  7 in total

Review 1.  [Antihistaminergic antipsychotics cause weight gain].

Authors:  T Veselinović; H Himmerich
Journal:  Nervenarzt       Date:  2010-03       Impact factor: 1.214

2.  Selective serotonin reuptake inhibitors (SSRIs) inhibit insulin secretion and action in pancreatic β cells.

Authors:  Roi Isaac; Sigalit Boura-Halfon; Diana Gurevitch; Alla Shainskaya; Yechiel Levkovitz; Yehiel Zick
Journal:  J Biol Chem       Date:  2012-12-28       Impact factor: 5.157

3.  Obesogenic Medications and Weight Gain Over 24 Weeks in Patients with Depression: Results from the GUIDED Study.

Authors:  Jess G Fiedorowicz; Lisa Brown; James Li; Sagar V Parikh; Boadie W Dunlop; Brent P Forester; Richard C Shelton; Michael E Thase; Matthew Macaluso; Kunbo Yu; John F Greden
Journal:  Psychopharmacol Bull       Date:  2021-11-03

4.  [Predictive factors of depression and its therapy].

Authors:  H Himmerich; E Kohls; U Hegerl; C Rummel-Kluge
Journal:  Nervenarzt       Date:  2014-10       Impact factor: 1.214

5.  Plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium.

Authors:  Hubertus Himmerich; Dagmar Koethe; Andreas Schuld; Alexander Yassouridis; Thomas Pollmächer
Journal:  Psychopharmacology (Berl)       Date:  2004-11-25       Impact factor: 4.530

Review 6.  A consensus statement for safety monitoring guidelines of treatments for major depressive disorder.

Authors:  Seetal Dodd; Gin S Malhi; John Tiller; Isaac Schweitzer; Ian Hickie; Jon Paul Khoo; Darryl L Bassett; Bill Lyndon; Philip B Mitchell; Gordon Parker; Paul B Fitzgerald; Marc Udina; Ajeet Singh; Steven Moylan; Francesco Giorlando; Carolyn Doughty; Christopher G Davey; Michael Theodoros; Michael Berk
Journal:  Aust N Z J Psychiatry       Date:  2011-09       Impact factor: 5.744

7.  The TNF-alpha system: functional aspects in depression, narcolepsy and psychopharmacology.

Authors:  Mark Berthold-Losleben; Hubertus Himmerich
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.